Harbour Investments Inc. Increases Stock Position in Axon Enterprise, Inc $AXON

Harbour Investments Inc. raised its holdings in Axon Enterprise, Inc (NASDAQ:AXON) by 24.6% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 558 shares of the biotechnology company’s stock after purchasing an additional 110 shares during the period. Harbour Investments Inc.’s holdings in Axon Enterprise were worth $462,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently modified their holdings of AXON. TCTC Holdings LLC lifted its stake in shares of Axon Enterprise by 75.0% during the first quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company’s stock valued at $29,000 after buying an additional 24 shares during the period. Bartlett & CO. Wealth Management LLC lifted its stake in shares of Axon Enterprise by 132.0% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company’s stock valued at $31,000 after buying an additional 33 shares during the period. Banque Transatlantique SA purchased a new position in shares of Axon Enterprise during the first quarter valued at approximately $31,000. Catalyst Capital Advisors LLC purchased a new position in shares of Axon Enterprise during the first quarter valued at approximately $32,000. Finally, Flaharty Asset Management LLC purchased a new position in shares of Axon Enterprise during the first quarter valued at approximately $33,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Insider Transactions at Axon Enterprise

In related news, CEO Patrick W. Smith sold 10,000 shares of the stock in a transaction on Tuesday, October 7th. The stock was sold at an average price of $713.74, for a total value of $7,137,400.00. Following the completion of the sale, the chief executive officer directly owned 3,033,982 shares in the company, valued at approximately $2,165,474,312.68. This represents a 0.33% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Brittany Bagley sold 5,000 shares of the stock in a transaction on Monday, September 29th. The shares were sold at an average price of $713.88, for a total value of $3,569,400.00. Following the completion of the sale, the chief financial officer owned 93,592 shares of the company’s stock, valued at approximately $66,813,456.96. This represents a 5.07% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 59,932 shares of company stock worth $45,115,616 in the last quarter. 5.70% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several equities analysts recently issued reports on the stock. Morgan Stanley set a $885.00 price objective on shares of Axon Enterprise and gave the company an “overweight” rating in a research note on Friday, July 11th. JPMorgan Chase & Co. upped their price objective on shares of Axon Enterprise from $730.00 to $850.00 and gave the company an “overweight” rating in a research note on Thursday, July 17th. Bank of America upped their price objective on shares of Axon Enterprise from $895.00 to $1,000.00 and gave the company a “buy” rating in a research note on Wednesday, August 6th. UBS Group reaffirmed a “neutral” rating and set a $840.00 price target (up previously from $820.00) on shares of Axon Enterprise in a research note on Tuesday, August 5th. Finally, Northland Securities set a $800.00 price target on shares of Axon Enterprise in a research note on Tuesday, August 5th. Fourteen analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $841.64.

Axon Enterprise Stock Performance

NASDAQ:AXON opened at $683.13 on Tuesday. The company has a quick ratio of 2.71, a current ratio of 2.95 and a debt-to-equity ratio of 0.63. The company has a market cap of $53.63 billion, a P/E ratio of 168.67, a P/E/G ratio of 26.04 and a beta of 1.41. Axon Enterprise, Inc has a fifty-two week low of $422.38 and a fifty-two week high of $885.91. The firm’s 50 day moving average is $736.73 and its two-hundred day moving average is $720.91.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings results on Monday, August 4th. The biotechnology company reported $2.12 earnings per share for the quarter, topping analysts’ consensus estimates of $1.54 by $0.58. The company had revenue of $668.54 million for the quarter, compared to the consensus estimate of $641.77 million. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. Axon Enterprise’s revenue was up 32.6% on a year-over-year basis. During the same quarter last year, the firm posted $1.20 earnings per share. Axon Enterprise has set its FY 2025 guidance at EPS. Analysts expect that Axon Enterprise, Inc will post 5.8 EPS for the current year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.